JP2019537559A5 - - Google Patents

Download PDF

Info

Publication number
JP2019537559A5
JP2019537559A5 JP2019517991A JP2019517991A JP2019537559A5 JP 2019537559 A5 JP2019537559 A5 JP 2019537559A5 JP 2019517991 A JP2019517991 A JP 2019517991A JP 2019517991 A JP2019517991 A JP 2019517991A JP 2019537559 A5 JP2019537559 A5 JP 2019537559A5
Authority
JP
Japan
Prior art keywords
compound
nrr
formula
pyridin
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019517991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019537559A (ja
JP7089141B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/054668 external-priority patent/WO2018067422A1/en
Publication of JP2019537559A publication Critical patent/JP2019537559A/ja
Publication of JP2019537559A5 publication Critical patent/JP2019537559A5/ja
Application granted granted Critical
Publication of JP7089141B2 publication Critical patent/JP7089141B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019517991A 2016-10-03 2017-09-30 新規なjak1選択的阻害剤およびその使用 Active JP7089141B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662403660P 2016-10-03 2016-10-03
US62/403,660 2016-10-03
PCT/US2017/054668 WO2018067422A1 (en) 2016-10-03 2017-09-30 Novel jak1 selective inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2019537559A JP2019537559A (ja) 2019-12-26
JP2019537559A5 true JP2019537559A5 (OSRAM) 2021-03-04
JP7089141B2 JP7089141B2 (ja) 2022-06-22

Family

ID=61831161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019517991A Active JP7089141B2 (ja) 2016-10-03 2017-09-30 新規なjak1選択的阻害剤およびその使用

Country Status (20)

Country Link
US (2) USRE49834E1 (OSRAM)
EP (1) EP3509591B1 (OSRAM)
JP (1) JP7089141B2 (OSRAM)
KR (1) KR102399848B1 (OSRAM)
CN (2) CN113214278B (OSRAM)
AU (3) AU2017339417C1 (OSRAM)
CA (1) CA3039178A1 (OSRAM)
DK (1) DK3509591T3 (OSRAM)
EA (1) EA201990523A1 (OSRAM)
ES (1) ES2901216T3 (OSRAM)
HK (1) HK1253040A1 (OSRAM)
HR (1) HRP20211965T1 (OSRAM)
HU (1) HUE058120T2 (OSRAM)
IL (3) IL265358B (OSRAM)
MX (1) MX390005B (OSRAM)
NZ (1) NZ751284A (OSRAM)
PL (1) PL3509591T3 (OSRAM)
PT (1) PT3509591T (OSRAM)
RS (1) RS62695B1 (OSRAM)
WO (1) WO2018067422A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX390005B (es) 2016-10-03 2025-03-20 Hangzhou Highlightll Pharmaceutical Co Ltd Inhibidores selectivos de jak1 novedosos y usos de los mismos.
SI3568396T1 (sl) 2017-01-11 2021-04-30 Leo Pharma A/S Novi derivati amino-imidazopiridina koz zaviralci Janus kinaze in njihova farmacevtska uporaba
EA202191170A1 (ru) 2018-10-31 2021-07-27 Инсайт Корпорейшн Комбинированная терапия для лечения гематологических заболеваний
MA55201A (fr) * 2019-03-05 2022-01-12 Incyte Corp Inhibiteurs de la voie jak1 pour le traitement d'un dysfonctionnement chronique de l'allogreffe pulmonaire
TW202102222A (zh) * 2019-03-19 2021-01-16 美商英塞特公司 白斑病之生物標記物
CA3142629A1 (en) * 2019-06-06 2020-12-10 Highlightll Pharmaceutical (Hainan) Co., Ltd Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of salt
JP7320628B2 (ja) 2019-06-06 2023-08-03 ハンチョウ ハイライトゥル ファーマシューティカル カンパニー リミテッド フロイミダゾピリジン化合物の合成方法、フロイミダゾピリジン化合物の結晶形態およびそれらの塩の結晶形態
EP4153566A1 (en) 2020-05-19 2023-03-29 Bayer CropScience Aktiengesellschaft Azabicyclic(thio)amides as fungicidal compounds
JP7729845B2 (ja) 2020-06-10 2025-08-26 バイエル、アクチエンゲゼルシャフト 新規殺菌剤としてのアザビシクリル置換複素環
EP4351584A4 (en) * 2021-06-07 2025-04-23 The Regents of the University of California COMPOSITIONS AND METHODS FOR TREATING CELIAC DISEASE
IL313097A (en) * 2021-09-13 2024-07-01 Hangzhou Highlightll Pharmaceutical Co Ltd Methods of treating cns disorders
CN114213424B (zh) * 2021-12-30 2023-05-26 杭州高光制药有限公司 一种呋喃[3,2-b]并吡啶衍生物的合成方法
WO2025224600A1 (en) * 2024-04-21 2025-10-30 Biohaven Therapeutics Ltd. Treatment of alpha-synucleinopathies and neuroprotection
WO2025248468A1 (en) 2024-05-28 2025-12-04 Biohaven Therapeutics Ltd. Use of tyk2/jak1 inhibitors to treat amyloid-related imaging abnormalities (aria)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369172A (en) 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
EP0188040B1 (en) 1985-01-11 1991-08-14 Abbott Laboratories Limited Slow release solid preparation
JP2773959B2 (ja) 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
KR100501022B1 (ko) 1998-07-28 2005-07-18 다나베 세이야꾸 가부시키가이샤 장내 적소 방출형 제제
JP2000119271A (ja) 1998-08-12 2000-04-25 Hokuriku Seiyaku Co Ltd 1h―イミダゾピリジン誘導体
US6461631B1 (en) 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
US6800663B2 (en) 2002-10-18 2004-10-05 Alkermes Controlled Therapeutics Inc. Ii, Crosslinked hydrogel copolymers
WO2005085227A1 (en) 2004-03-02 2005-09-15 Smithkline Beecham Corporation Inhibitors of akt activity
CN101277965A (zh) * 2005-08-04 2008-10-01 西特里斯药业公司 作为SIRTUIN调节化合物的咪唑并[2,1-b]噻唑衍生物
CA2775942A1 (en) * 2009-09-29 2011-04-07 Xcovery Holding Company Llc Pi3k (delta) selective inhibitors
WO2012022045A1 (en) * 2010-08-20 2012-02-23 Hutchison Medipharma Limited Pyrrolopyrimidine compounds and uses thereof
MX2013003913A (es) 2010-10-08 2013-09-26 Abbvie Inc Compuestos de furo [3, 2-d] pirimidina.
WO2013007768A1 (en) 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors
AU2012295802B2 (en) 2011-08-12 2017-03-30 Nissan Chemical Industries, Ltd. Tricyclic heterocyclic compounds and JAK inhibitors
CA2888816A1 (en) 2012-11-01 2014-05-08 Incyte Corporation Tricyclic fused thiophene derivatives as jak inhibitors
EP3060234A1 (en) 2013-10-24 2016-08-31 AbbVie Inc. Jak1 selective inhibitor and uses thereof
CR20160553A (es) 2014-04-30 2017-04-25 Incyte Corp Procesos para preparar un inhibidor de jak1 y nuevas formas de este
WO2015184305A1 (en) 2014-05-30 2015-12-03 Incyte Corporation TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
MX390005B (es) 2016-10-03 2025-03-20 Hangzhou Highlightll Pharmaceutical Co Ltd Inhibidores selectivos de jak1 novedosos y usos de los mismos.

Similar Documents

Publication Publication Date Title
JP2019537559A5 (OSRAM)
HRP20211965T1 (hr) Novi selektivni inhibitori jak1 i njihova upotreba
JP2006503888A5 (OSRAM)
JP2023085290A (ja) PI3K-γ阻害剤としての三級ヒドロキシ基で置換された縮合イミダゾール誘導体
RU2012132278A (ru) Трициклические гетероциклические соединения, содержащие их композиции и способы их применения
JP2017509689A5 (OSRAM)
JP2017519754A5 (OSRAM)
JP2017504576A5 (OSRAM)
CA2894016A1 (en) Modulators of the retinoid-related orphan receptor gamma (ror-gamma) for use in the treatment of autoimmune and inflammatory diseases
JP2015508092A5 (OSRAM)
JP2019504840A5 (OSRAM)
JP2012523440A5 (OSRAM)
BR112016008080B1 (pt) sal de ácido carboxílico ou um sal de ácido mineral, cristal de succinato, cristal de fumarato e composição farmacêutica
BR122021025062B1 (pt) Compostos agentes indutores de apoptose e processos para a preparação dos mesmos
JP2009538910A5 (OSRAM)
JP2016531868A5 (OSRAM)
JP2017519796A5 (OSRAM)
CA2958625A1 (en) Crystal of pyrrole derivative and method for producing the same
JP2017508733A5 (OSRAM)
RU2018103332A (ru) Пиримидиновое соединение с конденсированными кольцами, его промежуточное соединение, способ получения, композиция и применение
MX2015004467A (es) Proceso para preparar compuestos tienopirimidinas.
JP2015502371A5 (OSRAM)
MX2021014320A (es) Metodo para sintetizar el compuesto de furoimidazopiridina, sustancia polimorfica y sustancia polimorfica de sal.
JP2007500168A5 (OSRAM)
MX2016016488A (es) Derivados de azetidina sustituidos como ligandos de receptores asociados a aminas en trazas (taar).